Hayami Hiroshi, Takahashi Satoshi, Ishikawa Kiyohito, Yasuda Mitsuru, Yamamoto Shingo, Wada Koichiro, Kobayashi Kanao, Hamasuna Ryoichi, Minamitani Shinichi, Matsumoto Tetsuya, Kiyota Hiroshi, Tateda Kazuhiro, Sato Junko, Hanaki Hideaki, Masumori Naoya, Nishiyama Hiroyuki, Miyazaki Jun, Fujimoto Kiyohide, Tanaka Kazushi, Uehara Shinya, Matsubara Akio, Ito Kenji, Hayashi Kenji, Kurimura Yuichiro, Ito Shin, Takeuchi Toshimi, Narita Harunori, Izumitani Masanobu, Nishimura Hirofumi, Kawahara Motoshi, Hara Makoto, Hosobe Takahide, Takashima Kenji, Chokyu Hirofumi, Matsumura Masaru, Ihara Hideari, Uno Satoshi, Monden Koichi, Sumii Toru, Kawai Shuichi, Kariya Satoru, Sato Takashi, Yoshioka Masaru, Kadena Hitoshi, Matsushita Shinji, Nishi Shohei, Hosokawa Yukinari, Shirane Takeshi, Yoh Mutsumasa, Watanabe Syuji, Makinose Shinichi, Uemura Tetsuji, Goto Hirokazu
The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Blood Purification Center, Kagoshima University Hospital, Kagoshima, Japan.
The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
J Infect Chemother. 2019 Jun;25(6):413-422. doi: 10.1016/j.jiac.2019.02.021. Epub 2019 Mar 21.
The Japanese Surveillance Committee conducted a second nationwide surveillance of antimicrobial susceptibility patterns of uropathogens responsible for acute uncomplicated cystitis (AUC) in premenopausal patients aged 16-40 years old at 31 hospitals throughout Japan from March 2015 to February 2016. In this study, the susceptibility of causative bacteria (Escherichia coli, Klebsiella pneumoniae, Staphylococcus saprophyticus) for various antimicrobial agents was investigated by isolation and culturing of organisms obtained from urine samples. In total, 324 strains were isolated from 361 patients, including E. coli (n = 220, 67.9%), S. saprophyticus (n = 36, 11.1%), and K. pneumoniae (n = 7, 2.2%). The minimum inhibitory concentrations (MICs) of 20 antibacterial agents for these strains were determined according to the Clinical and Laboratory Standards Institute (CLSI) manual. At least 93% of the E. coli isolates showed susceptibility to fluoroquinolones and cephalosporins, whereas 100% of the S. saprophyticus isolates showed susceptibility to fluoroquinolones and aminoglycosides. The proportions of fluoroquinolone-resistant and extended-spectrum β-lactamase (ESBL)-producing E. coli strains were 6.4% (13/220) and 4.1% (9/220), respectively. The antimicrobial susceptibility of K. pneumoniae was retained during the surveillance period, while no multidrug-resistant strains were identified. In summary, antimicrobial susceptibility results of our second nationwide surveillance did not differ significantly from those of the first surveillance. Especially the numbers of fluoroquinolone-resistant and ESBL-producing E. coli strains were not increased in premenopausal patients with AUC in Japan.
日本监测委员会于2015年3月至2016年2月期间,在日本全国31家医院对16至40岁绝经前急性单纯性膀胱炎(AUC)患者尿路致病菌的抗菌药物敏感性模式进行了第二次全国性监测。在本研究中,通过对尿液样本中分离培养的微生物进行检测,研究了致病细菌(大肠埃希菌、肺炎克雷伯菌、腐生葡萄球菌)对各种抗菌药物的敏感性。总共从361例患者中分离出324株菌株,其中大肠埃希菌(n = 220,67.9%)、腐生葡萄球菌(n = 36,11.1%)和肺炎克雷伯菌(n = 7,2.2%)。根据临床和实验室标准协会(CLSI)手册,测定了20种抗菌药物对这些菌株的最低抑菌浓度(MIC)。至少93%的大肠埃希菌分离株对氟喹诺酮类和头孢菌素类敏感,而100%的腐生葡萄球菌分离株对氟喹诺酮类和氨基糖苷类敏感。耐氟喹诺酮类和产超广谱β-内酰胺酶(ESBL)的大肠埃希菌菌株比例分别为6.4%(13/220)和4.1%(9/220)。肺炎克雷伯菌的抗菌药物敏感性在监测期间保持稳定,未发现多重耐药菌株。总之,我们第二次全国性监测的抗菌药物敏感性结果与第一次监测结果无显著差异。特别是在日本患有AUC的绝经前患者中,耐氟喹诺酮类和产ESBL的大肠埃希菌菌株数量没有增加。